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Penile Dysmorphic Disorder (PDD) is shorthand for men diagnosed with Body 
Dysmorphic Disorder, in whom the size or shape of the penis is their main, if not their 
exclusive, preoccupation causing significant shame or handicap. There are no specific 
measures for identifying men with PDD compared to men who are anxious about the 
size of their penis but do not have PDD. Such a measure might be helpful for treatment 
planning, reducing unrealistic expectations, and measuring outcome after any 
psychological or physical intervention. Our aim was, therefore, to validate a specific 
measure, termed the Cosmetic Procedure Screening Scale for PDD (COPS-P). Eighty-
one male participants were divided into three groups: a PDD group (n = 21), a small 
penis anxiety group (n = 37), and a control group (n = 23). All participants completed, 
the COPS-P as well as standardized measures of depression, anxiety, social phobia, 
body image, quality of life, and erectile function. Penis size was also measured. The 
final COPS-P was based on 9 items. The scale had good internal reliability and 
significant convergent validity with measures of related constructs. It discriminated 
between the PDD group, the small penis anxiety group, and the control group. This is 
the first study to develop a scale able to discriminate between those with PDD and men 
anxious about their size who did not have PDD. Clinicians and researchers may use the 
scale as part of an assessment for men presenting with anxiety about penis size and as 
an audit or outcome measure after any intervention for this population.  
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Small penis anxiety (also known as “small penis syndrome”) is found in men 
who have a normal-sized penis but are excessively anxious about its size. The 
definition excludes men who have a micropenis (Wylie & Eardley, 2007). A 
micropenis has been defined as a penis < 7.5 cm in the erect length or < 4 cm in the 
flaccid state (Wessells, Lue, & McAninch, 1996). This is based on 2.5 SD below the 
mean for age. Thus, in a series of 250 men who complained of a small penis, 98% had 
normal penile measurements, two (0.8%) patients had a buried penis and only two 
(0.8%) had a true micropenis (Ghanem et al., 2007).  
Some men with small penis anxiety may be diagnosed with Body Dysmorphic 
Disorder (BDD) (American Psychiatric Association, 2013).  Individuals with BDD are 
preoccupied with a perceived defect or flaw in their physical appearance that is not 
observable to others or appears only slight. To fulfil the diagnostic criteria for BDD, 
they should be preoccupied for at least an hour a day (Phillips, 1996) and must also 
experience clinically significant distress or impairment in social, occupational, or other 
important areas of functioning. Individuals with BDD are frequently preoccupied with 
several features of the face or body. Occasionally, in men, it is focussed on their 
genitals (Phillips, Menard, Fay, & Weisberg, 2005; Veale, Boocock, et al., 1996; 
Veale et al., 2015). It is important to identify BDD, as it may be associated with a high 
rate of psychiatric hospitalization, suicide ideation, and completed suicide (Phillips, 
Coles, et al., 2005). It is often poorly identified because of shame and stigma, as 
patients do not often reveal their problem or they may present with symptoms of 
depression, social anxiety or obsessive-compulsive disorder when their main problem 
is BDD (Phillips, Nierenberg, Brendel, & Fava, 1996).  BDD can also be effectively 
treated with cognitive behavior therapy (CBT) (Veale, Anson, et al., 2014; Veale, 
Gournay, et al., 1996; Wilhelm et al., 2014) and SSRIs (Phillips, Albertini, & 
Rasmussen, 2002).  
 4 
 It is not known how many men with small penis anxiety also meet the criteria 
for BDD. A number of surgical studies have described men seeking phalloplasty as 
having penile dysmorphia but these were not reported as based on any structured 
diagnostic interview for BDD or a validated screening scale (Li et al., 2006; Perovic et 
al., 2006; Shamloul, 2005; Spyropoulos et al., 2005). We use the term “penile 
dysmorphic disorder” (PDD) in this study as a problem description for men diagnosed 
with BDD, in whom the size or shape of the penis is their main, if not their exclusive, 
preoccupation causing significant distress and shame or handicap. A similar problem 
description exists with “muscle dysmorphia”, a form of BDD in which patients 
(mainly men) are preoccupied with their muscles being too puny and are significantly 
distressed and handicapped (Pope, Gruber, Choi, Olivardia, & Phillips, 1997). This is 
now coded in DSM 5 as a separate sub-type of BDD.  
In clinical practice, sexual health physicians, urologists, counsellors, and 
psychotherapists may counsel men whose penis size is within the normal range, but 
who may be seeking a procedure to increase the length or girth of their penis. 
Cosmetic phalloplasty is still regarded as experimental without any adequate outcome 
or evidence of safety (Ghanem, Glina, Assalian, & Buvat, 2013). The diagnosis of 
BDD may be associated with poor outcome in most cosmetic procedures (Crerand, 
Menard, & Phillips, 2010; Phillips, Grant, Siniscalchi, & Albertini, 2001; Tignol, 
Biraben-Gotzamanis, Martin-Guehl, Grabot, & Aouizerate, 2007; Veale, De Haro, & 
Lambrou, 2003). Therefore, a urologist who offers phalloplasty to men with PDD 
would be unwise but it might be used as an experimental intervention in men without 
BDD. There have also not been any trials of standard treatments (e.g., CBT, SSRIs) in 
men with PDD as clinically they may be more difficult to engage and treat compared 
to other appearance concerns with BDD in both sexes.     
Most men with small penis anxiety are too ashamed to seek help and may 
instead seek solutions on the Internet. These include visiting sites that promote lotions, 
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pills, exercises or penile extenders. There is one case series of a penile extender for 
men (Gontero et al., 2009) that used the Erectile Function subscale of the International 
Index of Erectile Function and a non-validated satisfaction questionnaire at post-
treatment only. There are no case series or controlled trials of any psychological 
intervention for men with small penis anxiety, with or without PDD, other than an 
outcome of preventing surgery to increase size (Ghanem et al., 2007; Shamloul, 2005). 
One problem is that there are no adequate outcome measures for interventions. Using 
non-validated measures is problematic for several reasons: first, comparisons of 
findings between studies are difficult or impossible. Second, inadequate psychometric 
data make assessment of the effect size of any treatment difficult.  
The aim of the current study was to develop (1) a screening questionnaire that 
was brief, free to download, and could identify men with PDD who may require 
specialist assessment, (2) a research tool that might predict either dissatisfaction with a 
surgical intervention or no change or deterioration in overall symptoms of BDD, and 
(3) a measure that is potentially sensitive to change after any intervention and can be 
used for future audits and controlled trials in the treatment of men with anxieties about 
the size of their penis.   
METHOD 
Participants 
Participants were categorized as (1) men with small penis anxiety with PDD, 
(2) men with small penis anxiety without PDD, and (3) a control group of men 
unconcerned with their penis size. All men were recruited from one of three sources: 
(1) staff and students at King’s College London (n = 38), (2) the Mind Search database 
of volunteers at the Institute of Psychiatry, Kings College London (n = 4), and (3) a 
link on the website for a popular television series “Embarrassing Bodies” 
http://www.channel4embarrassingillnesses.com. It raises awareness of body image and 
illness concerns while allowing members of the public to understand their own 
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embarrassing bodily concerns (n = 39). In total, 81 participants were included in the 
study. The demographic data are shown in Table 1.  
Measures  
             All participants completed the following questionnaires online.  
Demographic Information          
            Information was obtained on age, marital status, ethnic origin, education, 
sexual orientation, and employment status. 
Cosmetic Procedure Screening Scale for PDD (COPS-P)  
This questionnaire was based on the original COPS for general appearance 
concerns and is a 9-item self-report scale (Veale et al., 2013). This is validated as a 
screening questionnaire for identifying BDD. We modified the wording to focus on 
worries about the penis (see Table and Appendix 1 for final version). Participants 
respond on a Likert scale ranging from 0 (“Not at all”) to 8 (“Extremely”). Questions 1 
and 3 are reverse scored. A total score was calculated by summing all items. Higher 
scores reflect increased preoccupation and distress over the shape or size of the penis 
and therefore the likelihood of a diagnosis of BDD.  
Beliefs about Penis Size (BAPS) (Veale, Eshkevari, et al., 2014)   
The BAPS is a 10-item self-report scale that measures beliefs about 
masculinity and shame about penis size. Two of the items measure internal self-
evaluative beliefs, such as feeling abnormal (e.g., “I will never feel just right”). Three 
items describe a social cognitive component with predictions such as “Others will talk 
about my penis or laugh at it”. There are four items on anticipated consequences of a 
small penis size, such as having to avoid situations where they may be naked (e.g., “I 
will not be able to be naked in front of women”). Lastly, there are two items on 
extreme self-consciousness (e.g., “Others will be able to see the size or shape of my 
penis even when I have my trousers on”). 
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The participant was asked to rate how strongly he agreed or disagreed with 
each statement, using a 5-point Likert scale from 0 (“Strongly disagree”) to 4 
(“Strongly agree”). Total scores ranged from 0 to 40. A higher score therefore 
represents a greater level of insecurity and shame about penis size. Cronbach’s alpha 
for the scale was .95, indicating strong internal reliability.  
Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) 
 The 14 items corresponding to the depression and anxiety subscales from the 
HADS were used to examine the severity of these symptoms. Each subscale was 
comprised of seven items and the possible range of scores was from 0 to 21 on each 
subscale. Higher scores represent increased severity of anxiety and depression. 
Cronbach’s alpha for the Anxiety subscale was .86 and Depression subscale was .83. 
Social Phobia Inventory (SPIN) (Connor et al., 2000)  
The SPIN is a 17-item self-report scale that measures the severity of 
performance and social anxiety. None of the items is specific to sexual situations. The 
participant rated each item on a 5-point Likert scale. The possible range of scores was 
from 0 (not at all) to 4 (extremely). Higher scores represent increased severity of social 
phobia and has a cut-off score of >19. Cronbach’s alpha was .95. 
Body Image Quality of Life Inventory (BIQLI) (Cash & Fleming, 2002; Hrabosky et 
al., 2009) 
The BIQLI is a 19-item self-report scale that measures the impact of body 
image concerns on a broad range of life domains (e.g., social functioning, sexuality, 
emotional well-being). Each item was rated by the participant on a 7-point Likert 
Scale, ranging from -3 (very negative effect) to + 3 (very positive effect). The BIQLI 
is scored as an average numeric score of the 19 items where a more negative score 
reflects a more negative body image. Cronbach’s alpha was .97. 
International Index of Erectile Function (IIEF) (Rosen et al., 1997)   
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The IIEF is a 15-item self-report scale that has five subscales: Erectile 
Function (range, 0-30), Orgasmic Function (range, 0-10), Sexual Desire (range, 0-10), 
Intercourse Satisfaction (range, 0-15), and Overall Satisfaction (range, 0-10). Across 
all five subscales, a higher score indicates higher erectile function and satisfaction. 
Cronbach’s alpha for Erectile Function was .94, Orgasmic Function .89, Sexual Desire 
.87, Intercourse Satisfaction .94, and Overall Satisfaction .89.  
Procedure 
            We sought in our email to recruit men to a study that was interested in their 
beliefs and fears about their penis size. They had to be aged 18 years or older and 
proficient in English in order to provide consent and complete the questionnaires 
online. All participants were interviewed by a trained research worker using the BDD 
Module in the Structured Clinical Interview for DSM-IV disorders (SCID) (First, 
Spitzer, Gibbon, & Williams, 1995). This was to see whether or not their 
preoccupation with their penis size met criteria for a diagnosis of BDD.  Criteria for 
meeting diagnosis according to the SCID are being preoccupied by the feature of 
concern for an hour or more per day, and if the preoccupation causes significant 
distress and impairment in social or occupational functioning. In addition, the 
symptoms must not be accounted for by another mental disorder.  Those who met all 
of the criteria were classified in the PDD group. If they were anxious about penis size 
and did not have BDD, then they were categorized in the SPA group. Participants were 
measured (flaccid and erect, length and girth) by a urologist in a hospital outpatient 
clinic. On arrival, participants completed a consent form and were then given privacy 
in an air-conditioned consulting room at a constant temperature (21°C) at sea level. 
Using a disposable tape measure, each participant had three parameters measured: 
circumference (girth) of the penile mid shaft; length from suprapubic skin to distal 
glans (skin-to-tip); and pubis to distal glans (bone-to-tip). The three measurements 
were recorded in the stretched flaccid state, grasping the glans and exerting a 
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stretching force until the participant felt mild discomfort to obtain maximum stretch.  
           After the flaccid measurements were taken, each participant was offered the 
chance to watch pornography on a provided laptop. Watching pornography was either 
accepted and chosen privately and anonymously or declined. At this point, the 
urologist left the room. Participants pressed a digital bell to alert the urologist when 
they were erect and ready to repeat the measurements. Three men were unable to 
achieve full erection and they received an intra-cavernous injection of 10 micrograms 
of Prostaglandin E1, administered by a urologist. The three measurements were then 
repeated in the fully erect state without stretching. Participants were given a £10 
shopping voucher to thank them for participating in each part of the study.  
Statistical Analysis 
The three groups were initially compared on demographic variables. The 
groups were then compared on COPS-P item scores. As scores were significantly 
different to a normal distribution, Kruskal-Wallis and post-hoc Mann-Whitney-U tests 
were used to determine which items of the COPS-P were most sensitive at 
discriminating between the PDD group and those with small penis anxiety, without 
PDD. The most sensitive items were used to form the final questionnaire. Receiver 
Operating Characteristics (ROC) analysis was used to assess sensitivity and specificity 
of the COPS-P in discriminating between the PDD and small penis anxiety group. To 
determine the optimal cut-off value of the COPS-P for the identification of men with 
PDD, kappa coefficients were computed for different cut-off scores. The internal 
consistency was evaluated using Cronbach’s alpha. Spearman’s rho correlation was 
used between the COPS-P and the HAD Depression, HAD Anxiety, BAPS, SPIN, 
BIQL, IIEF subscales, overall satisfaction score, and importance attached to penis size 
and actual penis size to test convergent validity. In order to test for group theoretical 
differences, COPS-P scores from the control group were compared to participants with 
PDD and participants with small penis anxiety. Where multiple comparisons were 
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conducted, Bonferroni corrections were applied so all post-hoc effects are reported 
at a .0167 level of significance. To reduce missing data from partially completed 
questionnaires, the average score was computed for questionnaires where only one 
item was missing. This value was then entered for unanswered questions. Where more 
than one item was missing from a questionnaire, the average score was not computed 
and total scores were not included in the analyses  
RESULTS 
Demographics  
Men with PDD were significantly older than the small penis anxiety and 
control group participants (Table 1).  
Item Response  
Items that showed a significant difference between the groups and had an effect 
size (Cohen’s d) of at least 1.25 were retained in the item discriminatory analysis. This 
effect size was considered very strong and we chose it, as we hoped to keep the scale 
to nine items, as this was the length of the original COPS (Veale et al., 2011). Nine 
items met these criteria and were used to form the final questionnaire (see Table 2). 
Two items that featured in the original COPS for general appearance concerns (Veale 
et al., 2011) did not meet criteria to be included in the COPS-P. These items were 
items (1) frequency of checking and (6) interference with relationships or dating. 
These two items were, therefore, removed and were replaced by two items with higher 
effect size items (7) interference in sexual relationships and (11) interference in leisure 
activities.  
ROC Analysis of the COPS-P  
ROC analysis was conducted to explore cut-off scores, sensitivity, and 
specificity. Figure 1 represents the ROC curve for men with PDD compared to men 
with SPA. The area under the curve (AUC) was good (0.95, 95% CI = 0.90-1). To 
determine an optimal cut-off value, kappa coefficients were computed for each cut-off 
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score. The highest kappa coefficient indicated the optimal sensitivity and specificity 
for cut-off values. As shown in Table 3, a cut-off score of 40 yielded the highest kappa 
coefficient, sensitivity, and specificity (k = 0.82), based on the discrimination between 
those with PDD and those with small penis anxiety. On the basis of this cut-off score, 
14 (78%) cases of PDD were correctly classified. Table 4 shows the sensitivity, 
specificity, and kappa coefficients, for a range of COPS-P cut-off scores designed to 
discriminate between men with and without PDD.  
Reliability and Internal Consistency 
Internal consistency for the 9-item COPS-P was calculated. Cronbach’s alpha 
was .94 for all the participants, indicating good internal consistency. There were no 
items whose removal would improve the reliability of the measure. 
Concurrent Validity 
Concurrent validity was analyzed through Spearman’s rho correlations with 
related measures. We examined the relationship between the COPS-P and the BAPS, 
HADS-Depression, HADS-Anxiety, SPIN, BIQL, and IIEF subscales (see Table 4). 
The COPS-P measure was significantly correlated with all the other measures (except 
the IEEF Sexual Desire subscale), indicating strong concurrent validity. There was a 
strong positive correlation with the BAPS. There was moderate correlation with 
HADS-Anxiety and HADS-Depression, SPIN, BIQL and IIEF subscales of Erectile 
Function, Intercourse Satisfaction and Overall Satisfaction. The weakest correlation 
was with IIEF Orgasmic Function.  
The COPS-P scores were not significantly correlated with penis length in a 
flaccid bone to tip non-stretched measure (rs = .08, R2 = 0.7%). Scores were weakly 
negatively correlated with length measurements when the penis was in an erect state 
(rs = -.29, R2 = 8%, p < .05).  The COPS-P scores were not significantly correlated 
with penis girth in a flaccid (rs = -.19, R2 = 4%) or erect state (rs = -.15, R2 = 2%).  
Validity: Group Differences 
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Total 9-item COPS-P scores significantly differed between the three groups 
(see Table 5). COPS-P scores from the PDD group were significantly higher than 
those from the SPA group and the control group with large effect sizes. Additionally, 
COPS-P scores for those with SPA were significantly higher than control group scores.  
DISCUSSION 
 This is the first study to develop a scale that was able to discriminate between 
those who had small penis anxiety with BDD and those who did not. We were able to 
demonstrate that the 9-item measure had good internal consistency with high internal 
reliability. The scale correlated significantly with the HADS-Depression, HADS-
Anxiety, Body Image Quality of Life, Social Phobia, and all but one of the IIEF scales. 
Of note is that the weakest correlation of the COPS-P was with two IIEF subscales, 
“Orgasmic Function” and “Sexual Desire”, which would not be expected to be affected 
by worries about penis size. The COPS-P was not correlated with girth or non-erect 
penis length (and only weakly with erect size). This is consistent with previous 
research in body image that has found that there is no relationship between objective 
unusualness of a body feature and psychological distress (Moss, 2005; Ong et al., 
2007).  
The COPS-P is potentially part of an assessment of men presenting with small 
penis anxiety along with the Beliefs about Penis Size (Veale, Eshkevari, et al., 2014). 
Urologists and psychosexual counsellors can use such scales to help determine 
whether their patient may be best referred to a specialist psychiatric setting if they have 
possible BDD or can be treated by a sexual or health psychologist attached to the 
clinic. The COPS-P might be expected to correlate with the frequency of avoidance 
(e.g., of sexual situations or changing rooms); safety seeking behaviors (e.g., covering 
the genital area or use of objects to increase the bulk of the genital area) and cognitive 
processes (such as worry and self-focussed attention).  
Limitations and Future Directions 
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The main limitation of this study was the use of a non-clinical convenience 
population. Therefore, bias in the results may occur with confounding variables linked 
to participants who are willing to partake in research in comparison to those with more 
extreme symptoms of small penis anxiety or PDD who would not be comfortable 
participating in the research. However, our participants in the PDD or SPA groups 
reported feeling too ashamed to seek help from normal routes of referral. In addition, it 
was initially necessary to recruit a large enough sample to investigate the psychometric 
properties of the scale. Furthermore, while the sample were a non-clinical population, 
they did have the opportunity to simultaneously take part in a randomized controlled 
trial investigating the efficacy of a treatment for small penis anxiety.  
The self-report questionnaires being used to differentiate the control group may 
be limited by desirability bias and less reliable due to their inclusion of Likert scales, 
which can cause difficulty when operationalizing measures.  
We did not expect our sample to be conducted in a relatively large proportion 
of homosexual men. It may be that homosexuality is a risk factor for concern with 
penis size because homosexual men might have more opportunity to compare their 
size to other men. Those who are homosexual may also be more likely to search the 
recruitment website or be willing to take part in related research. Existing qualitative 
research in men worried by penis size has suggested that homosexual men are subject 
to a number of stereotypes relating to penis size, such as a larger size is both more 
satisfying and portrays masculinity, which are thought to be influenced by Western 
culture (Drummond & Filiault, 2007).   
Additionally, while the relationship did not reach significance, frequencies did 
suggest that more men with PDD were married in comparison to men with SPA. This 
may be related to the older age of the PDD group. Further research would need to 
investigate whether this is a true difference. For example, the influence of a partner’s 
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opinion on genitalia or existing marital problems may have contributed to the 
development of BDD.  
A further limitation was that no test retest reliability was conducted and so we 
are unable to conclude that the scale has external reliability. However, the original 
COPS for general appearance concerns (Veale et al., 2011) was tested for re-test 
reliability after 1 week and found that the measurement outcomes were consistent over 
time and strongly correlated (r = 0.87, p < .01). Future studies will be required to 
validate the scale in a clinical setting such as a urology or psychosexual clinic, and 
conduct test-retest reliability.  
The scale has not yet been validated for sensitivity to change after any 
treatment. However, it was able to differentiate between those men who had PDD and 
those who did not. Future studies will need to validate the scale in men who are 
undergoing any intervention to determine whether it is effective in reducing symptoms 
of BDD. Lastly, it will important to determine the characteristics of men with PDD 
and small penis anxiety to understand the phenomenology and the risk factors in the 
development of the problem.   
Conclusions   
The current study was an initial validation on a brief self-report scale that can 
be used by clinicians and researchers to screen for BDD and potentially for audit and 












COPS-P for men      
 
This questionnaire is about the way you feel about the size or appearance of your penis. Please read the 
questions carefully and circle the number which best describes the way that you feel about your penis. 
Please read the labels carefully to ensure you are circling the number that reflects how you feel, as some 
of the answers are worded in a reverse order. Please answer for how you feel over the past week. 
 
 
1) To what extent do you feel the size or appearance of your penis is defective or unattractive?   
 
0                1                 2                 3                4                 5                 6                 7                8 
|_________|_________|_________|_________|_________|_________|_________|_________| 
 
Very                            Markedly                         Moderately                           Slightly                     Not at all                                 
defective         defective         defective                           defective                        defective 
 
 
2) To what extent does the size or appearance of your penis currently cause you distress? 
 
0                1                 2                 3                 4                 5                 6                 7                 8 
|_________|_________|_________|_________|_________|_________|_________|_________| 
 
Not at all                      Slightly                           Moderately                         Markedly                          Extremely          




3) How often does the size or appearance of your penis currently lead you to avoid situations or 
activities? 
 
0                1                 2                 3                 4                 5                 6                 7                 8 
|_________|_________|_________|_________|_________|_________|_________|_________| 
 
Always        Avoid about                      Avoid about           Avoid about                   Never 
avoid                     three quarters                    half of the            a quarter    
       of the time                            time                               of the time          
 
 
4) To what extent does thinking about the size or appearance of your penis currently preoccupy you? 
That is, you think about it a lot and it is hard to stop thinking about it. 
 
 
0                1                 2                 3                 4                 5                 6                 7                 8 
|_________|_________|_________|_________|_________|_________|_________|_________| 
 
Not at all                     Slightly                           Moderately                             Very                              Extremely 
preoccupied              preoccupied                   preoccupied                       preoccupied            preoccupied 
 
5) If you have a regular partner, to what extent do your concerns about the size or appearance of your 
penis currently have an effect on an existing sexual relationship? (e.g. enjoyment of sex, frequency of 
sexual activity). If you do not have a regular partner, to what extent do your concerns about your penis 
currently stop you from developing a sexual relationship? 
 
0                1                 2                3                  4                 5                 6                 7                 8 
|_________|_________|_________|_________|_________|_________|_________|_________| 
 
Not at all                      Slightly                           Moderately                         Markedly                           Extremely              
                                               or avoid sex 
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6) How much do your concerns about the size or appearance of your penis currently interfere with your 
ability to work or study? (Please rate this even if you are not working or studying: we are interested in 
your ability to work or study). 
 
0                1                 2                3                  4                 5                 6                 7                 8 
|_________|_________|_________|_________|_________|_________|_________|_________| 
 
Not at all                      Slightly                           Moderately                         Markedly                            Extremely              
                                                or avoid sex 
 
 
7) To what extent do your concerns about the size or appearance of your penis currently interfere with 
your social life? (with other people, e.g. going to parties, pubs, clubs, outings, visits)  
 
 
0                1                 2                 3                 4                 5                 6                 7                 8 
|_________|_________|_________|_________|_________|_________|_________|_________| 
 
Not at all                      Slightly                           Moderately                          Markedly                             Very              
                                                                                                                                                                                    severely     
   
 
8) To what extent do your concerns about the size or appearance of your penis currently interfere with 
leisure activities? (for example being in a public changing room).  
 
0                1                 2                 3                 4                 5                 6                 7                 8 
|_________|_________|_________|_________|_________|_________|_________|_________| 
 
Not at all                     Slightly                           Moderately                          Markedly                              Very              
                                                                                                                                                                                    severely     
   
 
9) How much do you feel the size or appearance of your penis is the most important aspect of who you 
are? 
 
0                1                 2                3                  4                 5                 6                 7                 8 
|_________|_________|_________|_________|_________|_________|_________|_________| 
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